Conclusions This report showed that the silencing of CD147 by RNAi inhibited the proliferation and invasion of human gastric cancer cell line SGC7901 in vitro and increased its chemosensitivity to the anti-tumor drug cisplatin. Our findings suggested that CD147 might be a promising target for gastric cancer treatment. Acknowledgements This work was supported by National Natural Science Foundation Decitabine cost of China (No. 30873022)
and Science and Technology Development Foundation of Nanjing Medical University (No. 09NJMUM070). References 1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997, 47:5–27.PubMedCrossRef 2. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 2001,37(Suppl 8):S4-S66.PubMedCrossRef 3. Parkin DM: International variation. Oncogene
2004, 23:6329–6340.PubMedCrossRef 4. Tang Y, Kesavan P, Nakada Selleckchem Rapamycin MT, Yan L: Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2004, 2:73–80.PubMed 5. Kataoka H, DeCastro R, Zucker S, Biswas C: Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 1993, 53:3154–3158.PubMed 6. Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M: Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical
role in cancer progression. Pathol Int 2006, 56:359–367.PubMedCrossRef 7. Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, Bugelski P, Yan L: Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer 3-mercaptopyruvate sulfurtransferase Res 2005, 65:3193–3199.PubMed 8. Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P, Yan L: Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Mol Cancer Res 2006, 4:371–377.PubMedCrossRef 9. Misra S, Ghatak S, Zoltan-Jones A, Toole BP: Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 2003, 278:25285–25288.PubMedCrossRef 10. Yang JM, Xu Z, Wu H, Zhu H, Wu X, Hait WN: Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003, 1:420–427.PubMed 11. Marieb EA, Zoltan-Jones A, Li R, Misra S, Ghatak S, Cao J, Zucker S, Toole BP: Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res 2004, 64:1229–1232.PubMedCrossRef 12.